News
-
-
PRESS RELEASE
Catheter Precision, Inc. (NYSE American: VTAK) Reports Q2 2024 Highlights and Operational Performance Report
Catheter Precision, Inc. releases Q2 Financials and Operational Report showcasing operational highlights and financial results. Company focuses on cardiac electrophysiology products VIVO and LockeT -
-
-
-
-
-
PRESS RELEASE
Catheter Precision, Inc. Announces the Completion of Patient Follow-up for the VIVO European Registry and New Product Evaluations of VIVO
Catheter Precision, Inc. announced the conclusion of the patient follow-up phase for the VIVO European Registry. Data to be available Q4 2024, ongoing evaluations and studies for VIVO and LockeT -
-